E-resources
Peer reviewed
Open access
-
Hunyady, Peter; Streller, Lea; Rüther, Darius F; Groba, Sara Reinartz; Bettinger, Dominik; Fitting, Daniel; Hamesch, Karim; Marquardt, Jens U; Mücke, Victoria T; Finkelmeier, Fabian; Sekandarzad, Asieb; Wengenmayer, Tobias; Bounidane, Ayoub; Weiss, Felicitas; Peiffer, Kai-Henrik; Schlevogt, Bernhard; Zeuzem, Stefan; Waidmann, Oliver; Hollenbach, Marcus; Kirstein, Martha M; Kluwe, Johannes; Kütting, Fabian; Mücke, Marcus M
Clinical infectious diseases, 02/2023, Volume: 76, Issue: 3Journal Article
Secondary sclerosing cholangitis (SSC) is a rare disease with poor prognosis. Cases of SSC have been reported following coronavirus disease 2019 (COVID-SSC). The aim of this study was to compare COVID-SSC to SSC in critically ill patients (SSC-CIP) and to assess factors influencing transplant-free survival. In this retrospective, multicenter study involving 127 patients with SSC from 9 tertiary care centers in Germany, COVID-SSC was compared to SSC-CIP and logistic regression analyses were performed investigating factors impacting transplant-free survival. Twenty-four patients had COVID-SSC, 77 patients SSC-CIP, and 26 patients other forms of SSC. COVID-SSC developed after a median of 91 days following COVID-19 diagnosis. All patients had received extensive intensive care treatment (median days of mechanical ventilation, 48). Patients with COVID-SSC and SSC-CIP were comparable in most of the clinical parameters and transplant-free survival was not different from other forms of SSC (P = .443, log-rank test). In the overall cohort, the use of ursodeoxycholic acid (UDCA) (odds ratio OR, 0.36 95% confidence interval {CI}, .16-.80, P = .013; log-rank P < .001) and high serum albumin levels (OR, 0.40 95% CI, .17-.96, P = .040) were independently associated with an increased transplant-free survival, while the presence of liver cirrhosis (OR, 2.52 95% CI, 1.01-6.25, P = .047) was associated with worse outcome. Multidrug-resistant organism (MDRO) colonization or infection did not impact patients' survival. COVID-SSC and CIP-SSC share the same clinical phenotype, course of the disease, and risk factors for its development. UDCA may be a promising therapeutic option in SSC, though future prospective trials are needed to confirm our findings.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.